Sohngen
Gary W. Sohngen, San Pedro, CA US
Patent application number | Description | Published |
---|---|---|
20120157997 | Fixation Instrument for Treating a Bone Fracture - A fixation instrument for treating a bone fracture including a bone screw and a nail, wherein the bone screw extends through an opening in the head or proximal end of the nail. A movable insert is disposed within a chamber located at the proximal end of the nail. The insert engages the bone screw to prevent rotation thereof once the bone screw is placed in position. | 06-21-2012 |
Mariola Sohngen, Deutschland DE
Patent application number | Description | Published |
---|---|---|
20090263373 | NON-NEUROTOXIC PLASMINOGEN ACTIVATING FACTORS FOR TREATING OF STROKE - The invention concerns the use and the production of non-neurotoxic plasminogen activating factors, derived, for example, from the common vampire | 10-22-2009 |
Wolfgang Sohngen, Deutschland DE
Patent application number | Description | Published |
---|---|---|
20090263373 | NON-NEUROTOXIC PLASMINOGEN ACTIVATING FACTORS FOR TREATING OF STROKE - The invention concerns the use and the production of non-neurotoxic plasminogen activating factors, derived, for example, from the common vampire | 10-22-2009 |
Wolfgang Sohngen, Aachen DE
Patent application number | Description | Published |
---|---|---|
20080213244 | Glutamate Receptor Antagonists as Neuroprotectives - The invention relates to the use of inhibiting agents of t-PA-mediated activation of the glutamate receptor, for example of the NMDA type, as neuroprotectives. | 09-04-2008 |
20090004176 | NON-NEUROTOXIC PLASMINOGEN ACTIVATING FACTORS FOR TREATING OF STROKE - The invention pertains to the use and production of non-neurotoxic plasminogen activating factors e.g. of | 01-01-2009 |
20130039902 | NON-NEUROTOXIC PLASMINOGEN ACTIVATING FACTORS FOR TREATING OF STROKE - The invention concerns the use and the production of non-neurotoxic plasminogen activating factors, derived, for example, from the common vampire | 02-14-2013 |
20140199287 | NON-NEUROTOXIC PLASMINOGEN ACTIVATING FACTORS FOR TREATING OF STROKE - The invention concerns the use and the production of non-neurotoxic plasminogen activating factors, derived, for example, from the common vampire | 07-17-2014 |